Explore how AI phenotypic screening transforms image-based drug discovery through advanced phenotypic data analysis and ML-driven cell-based assays.

Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered ...

Cardiovascular diseases remain a leading cause of mortality globally, driving the need for more precise diagnostic and predictive tools. Traditional ...

The technology has some promising applications, but is not ready for whole body cancer screening and will not replace other ...

Agilent introduces AI-driven analysis module for Agilent xCELLigence RTCA eSight: Santa Clara, California Friday, July 3, 2026, 12:00 Hrs [IST] Agilent Technologies Inc., a global ...

The Flexible Plastic Packaging Market is poised for sustained growth, driven by rising demand from the food & beverage, healthcare, personal care, and e-commerce sectors. Leading players are strengthe ...

Tripo Studio, an AI-powered 3D content creation platform, announced continued growth in the use of artificial intelligence ...

Classiq and Pontificia Universidad Católica de Chile (UC Chile) have announced a joint research project to develop hybrid quantum algorithms for biomedical image analysis – assisted by classical ...

Open-Source AI Tools while not widely publicized, are highly regarded within the developer community for their ability to simplify complex tasks ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new platform that combines 3D bioprinting ...

Researchers developed a platform combining 3D bioprinting, imaging and AI to monitor drug responses in tumor organoids. It ...

Mistral AI has introduced Mistral OCR 4, a new optical character recognition (OCR) model designed for enterprise document ...